AAN: Mediterranean Diet Score Linked to Cognition in MS
THURSDAY, March 2, 2023 (HealthDay News) — The Mediterranean diet score is associated with cognition among persons with multiple sclerosis (MS), according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of…
Learn MoreCould the Mediterranean Diet Help People With MS?
THURSDAY, March 2, 2023 (HealthDay News) — A Mediterranean diet may help multiple sclerosis (MS) patients ward off damage to their thinking skills.New research finds that a diet rich in veggies, fruit, fish and healthy fat reduced their risk of devel…
Learn MoreEvidence Found of Causal Link for Multisite Chronic Pain and MS, RA
WEDNESDAY, Feb. 22, 2023 (HealthDay News) — Multisite chronic pain is causally associated with a higher risk for multiple sclerosis (MS) and rheumatoid arthritis (RA), but not with other autoimmune diseases (AIDs), according to a study published onli…
Learn More¿Dormir mal en la adolescencia aumenta el riesgo de EM?
MIÉRCOLES, 25 de enero de 2023 (HealthDay News) — Los adolescentes que duermen mal de noche con regularidad quizá se enfrenten a un riesgo más alto de desarrollar esclerosis múltiple (EM) en la adultez, sugiere una investigación reciente. “Encontramo…
Learn MoreAdolescent Sleep Patterns Tied to Later Multiple Sclerosis Risk
WEDNESDAY, Jan. 25, 2023 (HealthDay News) — Insufficient sleep and low sleep quality during adolescence may increase the risk for subsequently developing multiple sclerosis, according to a study published online Jan. 23 in the Journal of Neurology, N…
Learn MoreCould Bad Sleep in Teen Years Raise Risks for MS?
WEDNESDAY, Jan. 25, 2023 (HealthDay News) — Teens who regularly fail to get a good night’s sleep may face a higher risk for developing multiple sclerosis (MS) as adults, new research suggests.“We found that sleeping too little or experiencing poor sl…
Learn MoreAberrations Identified in Gut Microbiota of Multiple Sclerosis Patients
MONDAY, Jan. 9, 2023 (HealthDay News) — Considerable alterations in the gut microbiota are seen in patients with multiple sclerosis, according to a study published online Jan. 5 in Genome Medicine.Florence Thirion, from Université Paris-Saclay, and c…
Learn MoreUna terapia con células madre quizá ralentice a la EM mejor que los fármacos, según un estudio
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) — Un nuevo estudio amplía las evidencias de que las personas con esclerosis múltiple (EM) se pueden beneficiar de un tipo de trasplante de células madre, incluso los pacientes que están en una fase …
Learn MoreAutologous Hematopoietic Stem Cell Transplant Slows Disability Progression in MS
WEDNESDAY, Dec. 28, 2022 (HealthDay News) — For patients with active secondary progressive multiple sclerosis (SPMS), autologous hematopoietic stem cell transplantation (AHSCT) is associated with a slowing of disease progression compared with other a…
Learn MoreStem Cell Therapy May Slow MS Better Than Meds: Study
WEDNESDAY, Dec. 28, 2022 (HealthDay News) — A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant — including some patients who are in a more advanced phase of the disease.The research …
Learn More